Supporting Women's BIA-ALCL Decision-making: Role of the Individual Consult in Empowering the Patient-Physician Team.

Plast Reconstr Surg Glob Open

Departments of Surgery and Oncology, University of Calgary, Calgary, Alberta, Canada.

Published: October 2021

Background: Breast implant associated anaplastic large cell lymphoma (BIA-ALCL) is a T-cell non-Hodgkin's lymphoma and an uncommon risk of textured breast implants. Over the past decade, concern about BIA-ALCL has been increasing among both patients and surgeons. Patients are seeking a better understanding of their BIA-ALCL risk toward identifying a personalized care plan. This quality improvement project examines the value added by pairing group-based patient education seminars with one-on-one consults.

Methods: Individual consults were held following educational group seminars. Consult field notes underwent qualitative thematic analysis. Themes were cross referenced against a quantitative chart review of patient BIA-ALCL prophylaxis decisions over time.

Results: Four key themes were identified: weighing, perceiving, guiding, and supporting. considers the risk-benefit assessments patients make when weighing their BIA-ALCL risk. describes the underlying psychosocial factors that frame patient perceptions of BIA-ALCL risk. presents the levels of guidance that patients require when making BIA-ALCL prophylaxis decisions. explores the therapeutic value of the individual consult. Ultimately, 41% of post-seminar consult attendees sought explantation, compared with 4% among patients who did not participate in this program ( < 0.001).

Conclusions: Key lessons include the following: (1) patients weigh BIA-ALCL risk against perceived surgical risks and the value of their reconstruction; (2) patients can benefit from a personalized balance of autonomy and surgeon guidance when selecting a BIA-ALCL prevention plan; (3) surgeons should seek to understand the psychosocial factors that may underlie patient perceptions of BIA-ALCL risk; and (4) individual consults can be therapeutic and help strengthen the patient-surgeon relationship.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604015PMC
http://dx.doi.org/10.1097/GOX.0000000000003843DOI Listing

Publication Analysis

Top Keywords

bia-alcl risk
20
bia-alcl
11
individual consult
8
individual consults
8
bia-alcl prophylaxis
8
prophylaxis decisions
8
psychosocial factors
8
patient perceptions
8
perceptions bia-alcl
8
patients
7

Similar Publications

The (In-)Ability to Effectively Critique a Method Undermines the Validity of the Criticism.

Aesthetic Plast Surg

January 2025

Directorate General of Medical Devices and Pharmaceutical service of the Italian Ministry of Health, Via Ribotta 5, 00144, Rome, Italy.

Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors  www.springer.

View Article and Find Full Text PDF

Limitations of Estimating BIA-ALCL Incidence Risk Using Implant Sales Data and the Italian National Breast Implant Registry.

Aesthetic Plast Surg

December 2024

Department of Neuroscience, Mental Health and Sense Organs (NESMOS), Chair of Plastic Surgery, Azienda Ospedaliera Sant'Andrea, UOD of Plastic Surgery, Sapienza University of Rome, Faculty of Medicine and Psychology, Via di Grottarossa 1035-1039, 00189, Rome, Italy.

Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.

View Article and Find Full Text PDF

Breast implant-associated anaplastic large cell lymphoma in Romania: First case series of all documented cases.

J Plast Reconstr Aesthet Surg

December 2024

Carol Davila University of Medicine and Pharmacy; Department of Plastic and Reconstructive Surgery, Prof. Dr. "Agrippa Ionescu" Clinical Emergency Hospital, Bucharest, Romania.

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), an uncommon malignancy, was linked to textured breast implants by moderate evidence in 2021. Documenting Romanian cases provides valuable insights into the epidemiology, management, and outcomes, thereby, enhancing global understanding and informing clinical practices. Our objective was to analyze BIA-ALCL cases in Romania, focusing on patient demographics, implant characteristics, clinical presentation, diagnostic methods, treatment, and outcomes.

View Article and Find Full Text PDF

Current Knowledge on Breast Implant-Associated Anaplastic Large Cell Lymphoma: Evidence from Italian Ministry of Health Registry Data.

Aesthetic Plast Surg

October 2024

Directorate General of Medical Devices and Pharmaceutical service, Italian Ministry of Health, Via Ribotta 5, 00144, Rome, Italy.

Background: Accurate estimation of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) incidence is crucial for assessing breast-implant-associated risk. However, the size of the implanted population worldwide is unknown, making it challenging to appropriately estimate this figure. This study aims to provide a new reliable and reproducible method to estimate the breast-implanted-population (BIP), reporting a reliable annual BIA-ALCL incidence estimate.

View Article and Find Full Text PDF

When a delayed seroma with a low volume is detected more than 1 year after silicone breast implant insertion, aspiration is necessary. However, if the seroma is small and difficult to collect, we may avoid puncturing it, considering the risk of damaging the implant, and the patient may be followed up intensively. Moreover, a delayed seroma is a major symptom of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!